Market Cap 49.48M
Revenue (ttm) 0.00
Net Income (ttm) -58.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 9,400
Avg Vol 23,718
Day's Range N/A - N/A
Shares Out 5.04M
Stochastic %K 61%
Beta 0.63
Analysts Strong Buy
Price Target $34.48
GridDrift_33
GridDrift_33 Oct. 2 at 3:15 PM
$ALVR NXXT at $1.94 with P S 4.9x lining for rerate to $5.5 once margins flip and EPS prints
0 · Reply
11thestate
11thestate Sep. 24 at 12:52 PM
$ALVR has agreed to settle with investors by paying $1 million to resolve claims that it misled them about the effectiveness of its lead product, Posoleucel. Who’s eligible? Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=09242025_1
0 · Reply
topstockalerts
topstockalerts Sep. 16 at 6:48 PM
$ALVR setting up nicely.. 👀
0 · Reply
11thestate
11thestate Sep. 11 at 10:36 PM
$ALVR has agreed to settle with investors by paying $1 million to resolve claims that it misled them about the effectiveness of its lead product, Posoleucel. Who’s eligible? Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=09112025_1
0 · Reply
11thestate
11thestate Sep. 4 at 2:39 AM
$ALVR investors, if you follow us, you already knew about it. This is the good news you needed about $ALVR today. Go check it out: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09032025_1 #AlloVir #ALVR
0 · Reply
11thestate
11thestate Aug. 26 at 3:55 AM
$ALVR has reached a $1 million settlement with investors to resolve claims that it misled them about the effectiveness of its lead product, Posoleucel. Who’s eligible? Anyone who purchased $ALVR shares between January 11, 2023, and December 21, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12 per share. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08262025_1
0 · Reply
11thestate
11thestate Aug. 15 at 4:45 AM
#AlloVir has reached a $1M settlement with $ALVR investors over claims that it misled them about the effectiveness of its lead product, Posoleucel. 📅 Class Period: Jan 11, 2023 – Dec 21, 2023 🗓️ Claim Deadline: Aug 19, 2025 If you purchased $ALVR during this period, you may be eligible for compensation here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=08152025_7
0 · Reply
11thestate
11thestate Aug. 13 at 10:43 AM
#AlloVir has reached a $1M settlement with $ALVR investors over claims it misled them about the effectiveness of its lead product, Posoleucel. 📅 Class Period: Jan 11, 2023 – Dec 21, 2023 🗓️ Claim Deadline: Aug 19, 2025 If you purchased $ALVR during this period, you may be eligible for compensation here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=08122025_1
0 · Reply
11thestate
11thestate Aug. 6 at 5:33 AM
AlloVir has reached a $1M settlement with $ALVR investors over claims that it misled them about the effectiveness of its lead product, Posoleucel. 📅 Class Period: Jan 11, 2023 – Dec 21, 2023 🗓️ Claim Deadline: Aug 19, 2025 If you bought $ALVR during this period, you can file a claim for payment here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=08062025_1
0 · Reply
11thestate
11thestate Jul. 28 at 1:12 PM
$ALVR losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/allovir-investor-settlement #AlloVir #ALVR
0 · Reply
Latest News on ALVR
Kalaris Announces Closing of Merger with AlloVir

Mar 18, 2025, 4:21 PM EDT - 7 months ago

Kalaris Announces Closing of Merger with AlloVir

KLRS


Kalaris and AlloVir Announce Stockholder Approval of Merger

Mar 12, 2025, 4:01 PM EDT - 7 months ago

Kalaris and AlloVir Announce Stockholder Approval of Merger


GridDrift_33
GridDrift_33 Oct. 2 at 3:15 PM
$ALVR NXXT at $1.94 with P S 4.9x lining for rerate to $5.5 once margins flip and EPS prints
0 · Reply
11thestate
11thestate Sep. 24 at 12:52 PM
$ALVR has agreed to settle with investors by paying $1 million to resolve claims that it misled them about the effectiveness of its lead product, Posoleucel. Who’s eligible? Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=09242025_1
0 · Reply
topstockalerts
topstockalerts Sep. 16 at 6:48 PM
$ALVR setting up nicely.. 👀
0 · Reply
11thestate
11thestate Sep. 11 at 10:36 PM
$ALVR has agreed to settle with investors by paying $1 million to resolve claims that it misled them about the effectiveness of its lead product, Posoleucel. Who’s eligible? Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=09112025_1
0 · Reply
11thestate
11thestate Sep. 4 at 2:39 AM
$ALVR investors, if you follow us, you already knew about it. This is the good news you needed about $ALVR today. Go check it out: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09032025_1 #AlloVir #ALVR
0 · Reply
11thestate
11thestate Aug. 26 at 3:55 AM
$ALVR has reached a $1 million settlement with investors to resolve claims that it misled them about the effectiveness of its lead product, Posoleucel. Who’s eligible? Anyone who purchased $ALVR shares between January 11, 2023, and December 21, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12 per share. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08262025_1
0 · Reply
11thestate
11thestate Aug. 15 at 4:45 AM
#AlloVir has reached a $1M settlement with $ALVR investors over claims that it misled them about the effectiveness of its lead product, Posoleucel. 📅 Class Period: Jan 11, 2023 – Dec 21, 2023 🗓️ Claim Deadline: Aug 19, 2025 If you purchased $ALVR during this period, you may be eligible for compensation here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=08152025_7
0 · Reply
11thestate
11thestate Aug. 13 at 10:43 AM
#AlloVir has reached a $1M settlement with $ALVR investors over claims it misled them about the effectiveness of its lead product, Posoleucel. 📅 Class Period: Jan 11, 2023 – Dec 21, 2023 🗓️ Claim Deadline: Aug 19, 2025 If you purchased $ALVR during this period, you may be eligible for compensation here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=08122025_1
0 · Reply
11thestate
11thestate Aug. 6 at 5:33 AM
AlloVir has reached a $1M settlement with $ALVR investors over claims that it misled them about the effectiveness of its lead product, Posoleucel. 📅 Class Period: Jan 11, 2023 – Dec 21, 2023 🗓️ Claim Deadline: Aug 19, 2025 If you bought $ALVR during this period, you can file a claim for payment here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=08062025_1
0 · Reply
11thestate
11thestate Jul. 28 at 1:12 PM
$ALVR losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/allovir-investor-settlement #AlloVir #ALVR
0 · Reply
11thestate
11thestate Jul. 17 at 11:40 AM
AlloVir has agreed to a $1M settlement with $ALVR investors over claims it misled them about the effectiveness of its lead product, Posoleucel. ⏳ Claim deadline: August 19, 2025 📅 Class Period: January 11, 2023 – December 21, 2023 If you bought $ALVR during that time, you can file a claim for payment here: https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate Jul. 9 at 8:15 PM
🧬 AlloVir has agreed to a $1M settlement with $ALVR investors over claims that it misled them about the effectiveness of its lead product, Posoleucel. ⏰ Claim deadline is August 19, 2025. If you bought $ALVR between January 11, 2023, and December 21, 2023, you can file a claim for payment here: https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate Jul. 1 at 8:21 PM
#AlloVir has agreed to settle $1M with $ALVR investors over claims that it misled them about the effectiveness of its lead product, Posoleucel. The deadline to file a claim is coming up: August 19, 2025. If you bought $ALVR between January 11, 2023, and December 21, 2023, you can file a claim for payment: https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate Jun. 23 at 8:18 PM
$ALVR investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #AlloVir $ALVR https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate Jun. 12 at 10:36 PM
Don’t forget that if you held $ALVR, there’s a significant settlement you can also claim. Consider it the dividend #AlloVir never paid. https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate Jun. 4 at 12:04 PM
Don’t forget that if you held $ALVR, there’s a significant settlement you can also claim. Consider it the dividend #AlloVir never paid. https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate May. 27 at 10:35 AM
$ALVR investors, if you follow us, you already knew about it. This is the good news you needed about $ALVR today. Go check it out. #AlloVir #ALVR https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate May. 20 at 4:29 PM
$ALVR agreed to a $1M settlement with investors over claims it made false or misleading statements about its business. Who’s eligible? Anyone who bought and held $ALVR stock through December 21, 2023. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.03 per share — but if only 25% of eligible investors file, it could go up to $0.12 per share. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Usually 4–9 months after the court grants final approval. To file your claim: https://11th.com/cases/allovir-investor-settlement
0 · Reply
11thestate
11thestate May. 12 at 11:24 AM
$ALVR agreed to a $1M settlement with investors over claims it misled them about the effectiveness of its lead treatment, Posoleucel, during failed Phase 3 trials. Who’s eligible? Anyone who bought and held $ALVR stock between January 11, 2023 and December 21, 2023. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.03 per share, depending on how many investors file. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after final approval. To file your claim: https://11th.com/cases/allovir-investor-settlement
0 · Reply
youspeaktome
youspeaktome May. 8 at 7:09 PM
$ALVR $KLRS Doing some work here and this should be valued at 30% of cash. Their drug is still in Phase 1 very early trials
0 · Reply
youspeaktome
youspeaktome May. 8 at 6:38 PM
$ALVR $KLRS @gilheydari it's a joke. Samsara has a huge conflict. The market is now valuing their pile of trash at less than 0
0 · Reply
gilheydari
gilheydari May. 7 at 4:45 PM
$ALVR Such merger and the only winner was this one Samsara BioCapital, L.P., valued their portfolio company with 5 people and no product at $400M
0 · Reply